CRISPR

CRISPR2-vcana

ID
ZDB-CRISPR-250429-7
Name
CRISPR2-vcana
Previous Names
None
Target
Sequence
5' - GTGGTGGTCTGCTGGGAGTACGG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
pd3001 vcana
Expression
Gene expression in Wild Types + CRISPR2-vcana
No data available
Phenotype
Phenotype resulting from CRISPR2-vcana
No data available
Phenotype of all Fish created by or utilizing CRISPR2-vcana
Phenotype Fish Conditions Figures
otic vesicle protrusion ab-cs-56 labeling decreased amount, abnormal WT + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 4 with image from Mori et al., 2024
otic vesicle protrusion extracellular matrix organization decreased process quality, abnormal WT + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 4 with image from Mori et al., 2024
semicircular canal morphogenesis decreased process quality, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle posterior protrusion decreased length, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle lateral protrusion decreased length, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle anterior protrusion decreased length, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle posterior protrusion decreased length, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
semicircular canal morphogenesis decreased process quality, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle lateral protrusion decreased length, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
heart edematous, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle anterior protrusion decreased length, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.